Drug discovery leader and cellular biochemist with extensive experience in protein chemistry, cell biology, immunology and molecular biology, contributing to 3 approved drugs and at least 8 others into IND-enabling studies. Biologics consultant specializing in Protein Sciences and Antibody Discovery with broad experience in downstream process development, cell-based assays and PK/PD assay development. Previously: • Senior Director, Head of Protein Sciences, Surrozen Inc: Led a department of up to 18 talented researchers in all aspects of therapeutic discovery, including: antibody discovery, protein/antibody engineering, protein expression/purification/characterization, cell-based assays in support of developing multi-specific, multi-valent proteins modulating the WNT pathway for regenerative medicine. • Director of Protein Sciences, BioMarin Pharmaceutical: Built a multifunctional group capable of small scale biologic production (up-stream and downstream), cell-based assays, protein chemistry and cellular biochemistry to support all aspects of therapeutic discovery and development agnostic of therapeutic modality and target area. • Discovery Project Leader: Development of gene replacement, protein and peptide therapeutics for rare genetic disorders with a focus on neuromuscular disease and skeletal dysplasia • Accomplishments include enzyme/protein replacement/substitution therapy product development involving protein production, modification, technology transfer, formulation development, and assay development.